FDA Announces First Nine Recipients of Priority Drug Review Vouchers
The FDA announced the first nine recipients of priority review vouchers, offering expedited drug review to products aligned with national health priorities.
In a recent announcement, the Food and Drug Administration revealed the recipients of the Commissioner’s National Priority Review vouchers. This program provides an expedited drug review to companies with products that align with the agency’s national health priorities.
President Trump highlighted one of the recipients, EMD Serono, at a White House news conference on expanding access to in vitro fertilization. EMD Serono agreed to lower the prices of its existing fertility drugs in exchange for a voucher for Pergoveris, which stimulates egg development and has already been approved in 74 countries.
- EMD Serono: Received a voucher for Pergoveris
- Other drugs on the list are not specified due to subscription requirements
President Trump highlighted EMD Serono at a White House news conference on expanding access to in vitro fertilization.
Author's summary: FDA announces first nine priority review voucher recipients.